Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Proteomics|March 30, 2004
Identification of circulating antibodies to tumor-associated proteins for combined use as markers of non-small cell lung cancerLi Zhong, Xuejun Peng, Giovanna E Hidalgo, et al.The Journal of Allergy and Clinical Immunology. in Practice|April 23, 2020
Tiotropium Respimat Efficacy and Safety in Asthma: Relationship to AgeDennis E Doherty, Eugene R Bleecker, Petra Moroni-Zentgraf, et al.International Journal of Chronic Obstructive Pulmonary Disease|February 16, 2012
Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPDDennis E Doherty, Donald P Tashkin, Edward Kerwin, et al.Allergy and Asthma Proceedings|February 8, 2012
Comparison of the Asthma in America and Asthma Insight and Management surveys: did asthma burden and care improve in the United States between 1998 and 2009?Robert A Nathan, Eli O Meltzer, Michael S Blaiss, et al.Allergy and Asthma Proceedings|February 8, 2012
Asthma management and control in the United States: results of the 2009 Asthma Insight and Management surveyKevin R Murphy, Eli O Meltzer, Michael S Blaiss, et al.Allergy and Asthma Proceedings|February 8, 2012
Asthma burden in the United States: results of the 2009 Asthma Insight and Management surveyEli O Meltzer, Michael S Blaiss, Robert A Nathan, et al.Allergy and Asthma Proceedings|February 8, 2012
Patient and physician asthma deterioration terminology: results from the 2009 Asthma Insight and Management surveyMichael S Blaiss, Robert A Nathan, Stuart W Stoloff, et al.International Journal of Chronic Obstructive Pulmonary Disease|February 16, 2012
Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trialDonald P Tashkin, Dennis E Doherty, Edward Kerwin, et al.International Journal of Chronic Obstructive Pulmonary Disease|February 16, 2012
Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trialsDonald P Tashkin, Dennis E Doherty, Edward Kerwin, et al.Journal of Hepatology|January 24, 2004
Large-scale gene profiling of the liver in a mouse model of chronic, intragastric ethanol infusionIon V Deaciuc, Dennis E Doherty, Ravshan Burikhanov, et al.Pageof 4